A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy
- PMID: 23853074
- DOI: 10.1093/eurheartj/eht251
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy
Abstract
Aims: Dilated cardiomyopathy (DCM) is one of the leading causes for cardiac transplantations and accounts for up to one-third of all heart failure cases. Since extrinsic and monogenic causes explain only a fraction of all cases, common genetic variants are suspected to contribute to the pathogenesis of DCM, its age of onset, and clinical progression. By a large-scale case-control genome-wide association study we aimed here to identify novel genetic risk loci for DCM.
Methods and results: Applying a three-staged study design, we analysed more than 4100 DCM cases and 7600 controls. We identified and successfully replicated multiple single nucleotide polymorphism on chromosome 6p21. In the combined analysis, the most significant association signal was obtained for rs9262636 (P = 4.90 × 10(-9)) located in HCG22, which could again be replicated in an independent cohort. Taking advantage of expression quantitative trait loci (eQTL) as molecular phenotypes, we identified rs9262636 as an eQTL for several closely located genes encoding class I and class II major histocompatibility complex heavy chain receptors.
Conclusion: The present study reveals a novel genetic susceptibility locus that clearly underlines the role of genetically driven, inflammatory processes in the pathogenesis of idiopathic DCM.
Keywords: DCM; Dilated cardiomyopathy; Genome-wide association study.
Similar articles
-
The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.Tissue Antigens. 2005 Sep;66(3):200-8. doi: 10.1111/j.1399-0039.2005.00457.x. Tissue Antigens. 2005. PMID: 16101831
-
The HLA class II allele DQB1 0309 is associated with dilated cardiomyopathy.Gene. 2013 Dec 1;531(2):180-3. doi: 10.1016/j.gene.2013.09.022. Epub 2013 Sep 16. Gene. 2013. PMID: 24050898
-
Inflammatory dilated cardiomyopathy (DCMI).Herz. 2005 Sep;30(6):535-44. doi: 10.1007/s00059-005-2730-5. Herz. 2005. PMID: 16170686 Review.
-
Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23.Eur Heart J. 2021 May 21;42(20):2000-2011. doi: 10.1093/eurheartj/ehab030. Eur Heart J. 2021. PMID: 33677556 Free PMC article.
-
[Familial dilated cardiomyopathy].Herz. 2005 Sep;30(6):529-34. doi: 10.1007/s00059-005-2732-3. Herz. 2005. PMID: 16170685 Review. German.
Cited by
-
The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy.Circ Res. 2021 May 14;128(10):1514-1532. doi: 10.1161/CIRCRESAHA.121.318157. Epub 2021 May 13. Circ Res. 2021. PMID: 33983834 Free PMC article. Review.
-
Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis.Cell Rep. 2022 Nov 8;41(6):111611. doi: 10.1016/j.celrep.2022.111611. Cell Rep. 2022. PMID: 36351411 Free PMC article.
-
Genetics of dilated cardiomyopathy: practical implications for heart failure management.Nat Rev Cardiol. 2020 May;17(5):286-297. doi: 10.1038/s41569-019-0284-0. Epub 2019 Oct 11. Nat Rev Cardiol. 2020. PMID: 31605094 Review.
-
Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216.Front Physiol. 2021 Dec 14;12:789690. doi: 10.3389/fphys.2021.789690. eCollection 2021. Front Physiol. 2021. PMID: 34970157 Free PMC article. Review.
-
Determined to Fail--the Role of Genetic Mechanisms in Heart Failure.Curr Heart Fail Rep. 2015 Oct;12(5):333-8. doi: 10.1007/s11897-015-0264-6. Curr Heart Fail Rep. 2015. PMID: 26233853 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources